Maha Zafar
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Roswell Park Comprehensive Cancer Center (2026); Columbia University Irving Medical Center (2021); Lahore General Hospital (2026); Mercy Hospital Springfield (2024); Sisters of Mercy Health System (2024–2025); Mayo Hospital (2021); Lebanese American University (2021); University at Buffalo, State University of New York (2026); Albany Medical Center Hospital (2021); University of Veterinary and Animal Sciences (2026)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Maha Gul Zafar's research interests encompass hematology-oncology, with a focus on solid-organ and hematologic malignancies, as well as cancer genetics. Her scholarly work includes a meta-analysis on the efficacy and safety of intravenous iron in patients with iron deficiency and heart failure with reduced ejection fraction, and a systematic review of tyrosine kinase inhibitors in immune thrombocytopenic purpura. She has also contributed to studies on the impact of glucagon-like peptide-1 receptor agonists on survival in metastatic breast cancer and the treatment of chronic lymphocytic leukemia with zanubrutinib.
Zafar's publications also extend to areas such as de-novo antineutrophil cytoplasmic antibody-associated vasculitis following COVID-19 vaccination and disseminated histoplasmosis in a renal transplant recipient. Her research portfolio demonstrates an engagement with various aspects of cancer treatment, immune responses, and metabolic conditions, reflecting a broad interest within the medical field. She has co-authored over 50 publications and has an h-index of 3.
Metrics
- h-index: 3
- Publications: 47
- Citations: 72
Positions
-
Hematology Oncology Fellow 2025–2029University at Buffalo, State University of New York ORCID
-
Internal Medicine Resident 2022–2025Arkansas College of Osteopathic Medicine Mercy Hospital Fort Smith, Department of Internal Medicine ORCID
Selected Publications
-
Abstract PS3-05-18: Non-breast cancer related germline mutations in breast cancer patients: a single institution experience (2026)
-
Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis (2025)
-
AML-463: Unraveling a Unique Presentation of Cold Agglutinin Disease in Myeloid Malignancy (2025)
-
Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma (2025)
-
Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis (2025)
-
Impact of Early Testing and Analysis of Germline Genetic Mutation in Patients with Breast Cancer: A Single Institution Experience (2025)
-
PATH-61. GENOMIC SIGNATURE IN NON-SMALL CELL LUNG CANCER PATIENTS METASTATIC TO BRAIN-A SINGLE INSTITUTION EXPERIENCE (2024)
-
MM-218 A Unique Presentation of Solitary Extramedullary Plasmacytoma (2024)
-
Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review (2024)
-
MM-361 Central Nervous System Relapse of Multiple Myeloma: A Case Report (2024)
-
MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review (2024)
-
TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis (2023)
-
TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis (2023)
-
Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials (2023)
Collaboration Network
Top Collaborators
- Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- PATH-61. GENOMIC SIGNATURE IN NON-SMALL CELL LUNG CANCER PATIENTS METASTATIC TO BRAIN-A SINGLE INSTITUTION EXPERIENCE
- Impact of Early Testing and Analysis of Germline Genetic Mutation in Patients with Breast Cancer: A Single Institution Experience
- Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma
- AML-463: Unraveling a Unique Presentation of Cold Agglutinin Disease in Myeloid Malignancy
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Impact of Early Testing and Analysis of Germline Genetic Mutation in Patients with Breast Cancer: A Single Institution Experience
- Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma
- Abstract PS3-05-18: Non-breast cancer related germline mutations in breast cancer patients: a single institution experience
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
Similar Researchers
Based on overlapping research topics